Evidence map›Paper›PMID 39885184›Full record

ArticleScientific reports2025

Variable power functional dilution adjustment of spot urine.

Thomas Clemens Carmine

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Thomas Clemens CarminePraxis Dr.Carmine, Etzelstrasse 21, Pfaeffikon SZ, 8808, Switzerland. thomas.carmine@hin.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spot-urinary biomarkers are crucial in medical, epidemiological, and environmental studies, but their variability due to hydration levels requires precise dilution adjustments. Traditional methods, like conventional creatinine correction (CCRC), are limited in compensating for variations in urine concentration, causing substantial inconsistencies, particularly at the extremes of the diuresis spectrum. While restricting the creatinine (CRN) range to 0.3-3 g/L is recommended to ensure result stability, this approach excludes a substantial proportion of samples and permits notable fluctuations within the accepted range. This study introduces a novel variable power functional creatinine correction method (V-PFCRC) to normalize analytes to 1 g/L CRN by utilizing uncorrected analyte levels and two analyte-specific coefficients, c and d. Based on extensive urinary total weight arsenic data (n = 5,553), the mathematical derivation of these coefficients is detailed in this paper and forms the foundation of the corrective V-PFCRC formulas. The generalizability of V-PFCRC was evaluated using large spot-urinary datasets for four additional metals and an extensive dataset of urinary iodine levels (n > 58,000) and blood iodine. Validation against conventional methods-assessing vital statistical data, residual CRN bias, and correlations with concurrently detected blood levels of total arsenic and iodine- demonstrated the superior performance of V-PFCRC in reducing residual CRN bias and enhancing blood-urine correlations. The V-PFCRC method effectively addresses nonlinear hydration bias and the exposure-dependent variability of this bias, providing a more accurate representation of exposure and supply levels. The adaptability and efficiency of V-PFCRC suggest its broad applicability across various scientific disciplines, potentially transforming the precision and reliability of urinary biomarkers.

Indexed as

CreatinineUrinalysisArsenicBiomarkersHumansIodineArsenicBiomarkersCreatinineIodineArsenicBiomarkersCreatinine correctionExposure studies.IodineNonlinear dilution adjustmentSpot urine

Identifiers

PMID39885184
PMCPMC11782553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.